Cautious addition of targeted therapy to PD-1 inhibitors after initial progression of BRAF mutant metastatic melanoma on checkpoint inhibitor therapy

Overview of attention for article published in BMC Cancer, November 2021

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 997 followers.

これなんか、どう？ TCR下流でもBRAFiでparadoxical activationあれば、BRAFi->ERKup https://t.co/d3gSveSMfG

New article: Cautious addition of targeted therapy to PD-1 inhibitors after initial progression of BRAF mutant metastatic melanoma on checkpoint inhibitor therapy https://t.co/3MLRfL3X1e #melanoma #oncology https://t.co/iNqzsRYnvY

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.